ClariVest Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,335
| Closed | -$524K | – | 846 |
|
|
2024
Q1 | $524K | Buy |
28,335
+31
| +0.1% | +$573 | 0.05% | 355 |
|
|
2023
Q4 | $886K | Sell |
28,304
-5,000
| -15% | -$157K | 0.05% | 282 |
|
|
2023
Q3 | $694K | Buy |
+33,304
| New | +$694K | 0.04% | 305 |
|
|
2021
Q1 | – | Sell |
-54,880
| Closed | -$2.93M | – | 733 |
|
|
2020
Q4 | $2.93M | Sell |
54,880
-400
| -0.7% | -$21.4K | 0.1% | 171 |
|
|
2020
Q3 | $2.28M | Sell |
55,280
-1,190
| -2% | -$49.1K | 0.07% | 204 |
|
|
2020
Q2 | $2.74M | Sell |
56,470
-64,581
| -53% | -$3.13M | 0.07% | 188 |
|
|
2020
Q1 | $5.11M | Sell |
121,051
-3,319
| -3% | -$140K | 0.15% | 104 |
|
|
2019
Q4 | $5.32M | Sell |
124,370
-38,196
| -23% | -$1.63M | 0.12% | 140 |
|
|
2019
Q3 | $5.85M | Buy |
+162,566
| New | +$5.85M | 0.13% | 152 |
|
|
2016
Q2 | – | Sell |
-36,254
| Closed | -$1.01M | – | 625 |
|
|
2016
Q1 | $1.01M | Buy |
+36,254
| New | +$1.01M | 0.03% | 282 |
|